NRG1 and its cognate receptor ErbB4 regulate the development of activity-driven glutamatergic synapse development (9), indicating that NRG1 signalling may contribute to schizophrenia pathophysiology in the context of the glutamate hypothesis of schizophrenia. This evidence concerns the gene ERBB4 and schizophrenia.